Walleye Capital LLC Passage Bio, Inc. Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$2.66 - $6.49 $49,616 - $121,057	-18,653 Closed	0 $0
Q4 2021 Mar 03, 2022	BUY	$6.24 - $10.2 $116,394 - $190,260	18,653 New	18,653 $118,000
Q3 2021 Nov 15, 2021	SELL	$9.73 - $15.52 $825,104 - $1.32 Million	-84,800 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$12.44 - $19.45 $1.05 Million - $1.65 Million	84,800 New	84,800 $1.12 Million

38.7M

7.7K

Ticker PASG
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 54,463,200
Market Cap $35.9M
Description
Passage Bio, Inc., a genetic medicines company, develops transformative therapies for central nervous system diseases. It develops PBGM01, which utilizes a proprietary, AAVhu68 capsid to deliver to the brain and peripheral tissues a functional GLB1 gene encoding lysosomal acid beta-galactosidase for infantile GM1; PBFT02, which utilizes an AAV1 ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.